AstraZeneca PLC (Delisted)
(XSWX:AZN)
CHF
95.03
0 (0%)
Market Cap: 188.14 Bil
Enterprise Value: 209.80 Bil
PE Ratio: 38.61
PB Ratio: 6.56
GF Score: 78/100 AstraZeneca PLC (XSWX:AZN) Transcripts
- Q1 2024 AstraZeneca PLC Earnings Call TranscriptApr 25, 2024Earnings
- AstraZeneca PLC Sustainability 2023 Highlights Summary Call TranscriptMar 22, 2024
- Q4 2023 AstraZeneca PLC Earnings Call TranscriptFeb 08, 2024Earnings
- AstraZeneca PLC at JPMorgan Healthcare Conference TranscriptJan 09, 2024
- Q3 2023 AstraZeneca PLC Earnings Call TranscriptNov 09, 2023Earnings
- Q2 2023 AstraZeneca PLC Earnings Call TranscriptJul 28, 2023Earnings
- AstraZeneca PLC at ASCO Investor Meeting (Virtual) TranscriptJun 05, 2023
- Q1 2023 AstraZeneca PLC Earnings Call TranscriptApr 27, 2023Earnings
- Q4 2022 AstraZeneca PLC Earnings Call TranscriptFeb 09, 2023CHF95.03Earnings
- Q4 2022 AstraZeneca PLC Earnings Presentation (Pre-Recorded) TranscriptFeb 09, 2023
- Q3 2022 AstraZeneca PLC Earnings Presentation TranscriptNov 10, 2022
- Q2 2022 AstraZeneca PLC Earnings Call TranscriptJul 29, 2022CHF95.03Earnings
- AstraZeneca PLC Meet AZN management: American Society of Clinical Oncology 2022 Annual Meeting TranscriptJun 06, 2022
- Q1 2022 AstraZeneca PLC Earnings Call TranscriptApr 29, 2022CHF95.03Earnings
- AstraZeneca PLC Investor Science Conference Call: ASCO GU 2022 TranscriptFeb 23, 2022
- Full Year 2021 AstraZeneca PLC Earnings Call TranscriptFeb 10, 2022CHF95Earnings
- AstraZeneca PLC Investor science conference call: ASCO GI 2022 TranscriptJan 24, 2022
- AstraZeneca PLC at OTC Markets and Deutsche Bank Depositary Receipts Virtual Investor Conference TranscriptNov 17, 2021
- Q3 2021 AstraZeneca PLC Earnings Call TranscriptNov 12, 2021CHF95Earnings
- AstraZeneca PLC ESMO Investor Science Conference Call TranscriptSep 20, 2021
- Q2 2021 AstraZeneca PLC Earnings Call TranscriptJul 29, 2021CHF95Earnings
- AstraZeneca PLC Meet AZN Management: Oncology - 2021 ASCO Annual Meeting TranscriptJun 07, 2021
- Q1 2021 AstraZeneca PLC Earnings Call TranscriptApr 30, 2021CHF95Earnings
- AstraZeneca PLC BioPharmaceuticals Virtual Event - New CVRM: Emerging Pipeline TranscriptMar 25, 2021
- AstraZeneca PLC BioPharmaceuticals Virtual Event - Opening and Q&A Session TranscriptMar 25, 2021
- Full Year 2020 AstraZeneca PLC Earnings Call TranscriptFeb 11, 2021CHF120Earnings
- AstraZeneca PLC to Acquire Alexion Pharmaceuticals Inc Call TranscriptDec 12, 2020
- Q3 2020 AstraZeneca PLC Earnings Call TranscriptNov 05, 2020CHF120Earnings
- AstraZeneca PLC Investor Conference Call: Farxiga's DAPA-CKD Trial at ESC 2020 TranscriptAug 30, 2020
- Q2 2020 AstraZeneca PLC Earnings Call TranscriptJul 30, 2020CHF120Earnings
- AstraZeneca PLC at ASCO Virtual Scientific Program TranscriptJun 01, 2020
- Q1 2020 AstraZeneca PLC Earnings Call TranscriptApr 29, 2020CHF97Earnings
- Silence Therapeutics PLC Collaboration With AstraZeneca and R&D Update Call TranscriptMar 25, 2020
- Full Year 2019 AstraZeneca PLC Earnings Call TranscriptFeb 14, 2020CHF98.97Earnings
- AstraZeneca PLC Investor Science Conference Call - ASH 2019 TranscriptDec 10, 2019
- AstraZeneca PLC Investor Science Conference Call - ACR 2019 TranscriptNov 13, 2019
- AstraZeneca PLC Investor Science Conference Call - ASN 2019 TranscriptNov 10, 2019
- Q3 2019 AstraZeneca PLC Earnings Call TranscriptOct 24, 2019CHF83.7Earnings
- AstraZeneca PLC Investor Science Conference Call: ESMO 2019 TranscriptSep 30, 2019
- AstraZeneca PLC Investor Science Conference Call: Farxiga's DAPA-HF trial at ESC TranscriptSep 01, 2019
- Q2 2019 AstraZeneca PLC Earnings Call TranscriptJul 25, 2019CHF81Earnings
- AstraZeneca PLC at ASCO Annual Meeting TranscriptJun 03, 2019
- AstraZeneca PLC Annual Shareholders Meeting TranscriptApr 26, 2019
- Q1 2019 AstraZeneca PLC Earnings Call TranscriptApr 26, 2019CHF77.4Earnings
- AstraZeneca PLC to Discuss Strategic Collaboration in Oncology of Trastuzumab Deruxtecan (DS-8201) with Daiichi Sankyo Co Ltd Call TranscriptMar 29, 2019
- Daiichi Sankyo Co Ltd and AstraZeneca PLC DS-8201 Strategic Collaboration Presentation TranscriptMar 29, 2019
- Full Year 2018 AstraZeneca PLC Earnings Call TranscriptFeb 14, 2019CHF71.46Earnings
- 1